Mallinckrodt plcMNK announced that it has entered into a purchase agreement with The Medicines Company MDCO. As per the agreement, Mallinckrodt will acquire three hemostasis drugs from The Medicines ...

Hemostasis Products Each of the three drugs being acquired is approved by the U.S. Food and Drug Administration (FDA) and also in a number of other countries. Introduced in 2009, RECOTHROM is widely ...

Aug 5 (Reuters) - Medicines Co said its experimental drug to help stop bleeding during surgery was found effective in a late-stage study, sending its shares up more than 2 percent. The drug, which met ...

Bayer will use T2 Biosystems’ T2 Magnetic Resonance technology platform (T2MR ®) under a multiyear hemostasis research collaboration whose value was not disclosed. The collaboration, disclosed today ...

The US Food and Drug Administration has cleared the Nexpowder endoscopic hemostasis system. Nexpowder (Medtronic) uses a noncontact, nonthermal, nontraumatic hemostatic powder that is sprayed through ...

Thrombosis is a major unmet need. Globally more than one in four people die from thromboembolic events. Many more suffer morbidity due to complications. These events occur despite the availability of ...